Program directory · Public Health Agency of Canada
Evidence for Health Promotion, and Chronic Disease and Injury Prevention
- Department
- Public Health Agency of Canada
- Program code
- BVP03 (PHAC)
- Core responsibility
- Health Promotion and Chronic Disease Prevention
- In Departmental Plans
- 2018-19 – 2025-26 · Appeared and later dropped
What it does
This Program collects and analyzes national surveillance data on maternal, child and youth health, seniors’ health, chronic disease, injury, health inequalities, and associated social, behavioural, and environmental determinants of health. It also carries out research to build a strong evidence base for action on public health .
The Program provides ongoing leadership, engagement and expert advice by collaborating with national and international partners, and contributing to the development and sharing of evidence-based knowledge products, guidelines, declarations, joint statements, and frameworks. By addressing emerging public health issues, priorities, and knowledge gaps, the Program aims to better inform the development of policy and program interventions within the Public Health Agency of Canada and across sectors to improve the health and health behaviours of Canadians.
Source: the department's Program Inventory, via GC InfoBase.
History and lineage
First appears in GC InfoBase's actual spending by program in 2018-19. The data does not record when a program was created; it may be older than its first appearance here, which is limited by the sources (program spending starts in 2010-11, Departmental Plans in 2018-19).
| Program | Relation | Years with data | Actual spending over those years |
|---|---|---|---|
| Evidence for Health Promotion, and Chronic Disease and Injury Prevention | This program | 2018-19 – 2027-28 | $494M |
No earlier or later program in the same department has a similar name.
Significant changes in scope and budget
Detected from the data: renames between plans, programs it appears to replace, merge with or split into (matched by name), year-over-year changes in spending of at least 25% and $5M, or in employees of at least 20% and 25 FTEs, linked budget measures, and results indicators added or dropped.
| Year | What changed | Source |
|---|---|---|
| 2019-20 | Employees (FTEs) 261, against 191 in 2018-19 (+37%). | FTEs (GC InfoBase) |
| 2019-20 | Spending $68.6M, against $51.6M in 2018-19 (+33%). | Actual spending (GC InfoBase) |
| 2020-21 | Indicators added: % of stakeholders using health promotion evidence | Departmental Results Framework (GC InfoBase) |
| 2024-25 | Spending $69.1M, against $93M in 2023-24 (−26%). | Actual spending (GC InfoBase) |
| 2027-28 | Planned employees (FTEs) 221, against 289 in 2026-27 (−24%). | FTEs (GC InfoBase) |
Success criteria
The program's indicators from its department's Departmental Results Framework: the target set in each year's plan, and the result reported the following year. Source: GC InfoBase.
Historical: targets against results
Bars: result reported. Dashed line: target.
| Report year | Target | Due | Result | Status |
|---|---|---|---|---|
| 2018-19 | ≥ 61.5% | 2019 | 59% A new surveying process and methodology has been implemented and this value will be updated for 2019-20 in April 2020. The updated value will include responses regarding evidence released on our online platforms from April 2017 to March 2020. | Not met |
| 2019-20 | ≥ 61.3% | 2020 | 68.5% | Met |
| 2020-21 | ≥ 79% | 2021 | 82% The % of stakeholders using evidence is an important measure of the utility of evidence products produced by the Branch. Formula/calculation: Standardized survey questions will be disseminated via multiple mechanisms (broadcast messages, links embedded in evidence products, product distribution lists, pop-up surveys, etc.). Surveys will inquire whether stakeholders are using products and how. Thi… | Met |
| 2021-22 | ≥ 79% | 2022 | 73% While the target was not met for 2021-22, the actual results value is within the stated “Acceptable” range of 70-85%. This range is part of the full indicator profile, and was approved by the Performance Measurement Executive Committee. The Public Health Infobase was used as the main platform for posting COVID-19 products which have collectively received millions of views. The estimate of 73% is… | Not met |
| 2022-23 | ≥ 79% | 2023 | 92% | Met |
| 2023-24 | ≥ 79% | 2024 | 89% | Met |
| 2024-25 | ≥ 89% | 2025 | 79% In 2024-25, 79% of stakeholders reported using HPCDP evidence products, reflecting a 10% decrease from the 89% target in 2023-24. This decline reflects the fewer overall survey responses, the exclusion of the opioid-related publications, and the release of a major product later in the year that did not allow sufficient time for stakeholders to report on their use of the product. | Not met |
Bars: result reported. Dashed line: target.
| Report year | Target | Due | Result | Status |
|---|---|---|---|---|
| 2020-21 | ≥ 57.3% | 2021 | 89% The % of stakeholders using evidence is an important measure of the utility of evidence products produced by the Branch Formula /Calculation: X=# of stakeholders/ users surveyed who report using knowledge and/skills learned through knowledge products/events Y=Total # of users surveyed %=X/Yx100 | Met |
| 2021-22 | ≥ 57.3% | 2022 | 97% 97% (1162/1198) MHPIF | Met |
Current: the 2026-27 plan's targets
No indicators in the 2026-27 plan.
Future goals: targets due after 2026-27
No targets with a later due date.
Spending and employees: planned against actual
Spending
Show the numbers
| Fiscal year | Planned | Actual |
|---|---|---|
| 2018-19 | $62.4M | $51.6M |
| 2019-20 | $67.4M | $68.6M |
| 2020-21 | $58.1M | $63.3M |
| 2021-22 | $68.1M | $67.9M |
| 2022-23 | $151M | $81M |
| 2023-24 | $74M | $93M |
| 2024-25 | $72.4M | $69.1M |
| 2025-26 | $54.9M | — |
| 2026-27 | $53.1M* | — |
| 2027-28 | $43.6M* | — |
Employees (FTEs)
Show the numbers
| Fiscal year | Planned | Actual |
|---|---|---|
| 2018-19 | 260 | 191 |
| 2019-20 | 246 | 261 |
| 2020-21 | 274 | 276 |
| 2021-22 | 299 | 302 |
| 2022-23 | 326 | 328 |
| 2023-24 | 321 | 340 |
| 2024-25 | 350 | 295 |
| 2025-26 | 290 | — |
| 2026-27 | 289* | — |
| 2027-28 | 221* | — |
Planned spending, plan by plan
Each row is one year's Departmental Plan and its forecast for the next three fiscal years; read a column down to see how the forecast for one year changed. The last row is what was actually spent. Click an amount for its source. Biggest changes in federal spending plans
| Plan | 2018-19 | 2019-20 | 2020-21 | 2021-22 | 2022-23 | 2023-24 | 2024-25 | 2025-26 | 2026-27 | 2027-28 |
|---|---|---|---|---|---|---|---|---|---|---|
| 2018-19 plan | $62,376,292 | $60,381,387 | $50,615,951 | |||||||
| 2019-20 plan | $67,424,547 | $56,846,911 | $55,665,250 | |||||||
| 2020-21 plan | $58,085,043 | $56,686,635 | $56,643,382 | |||||||
| 2021-22 plan | $68,102,856 | $57,287,297 | $54,135,311 | |||||||
| 2022-23 plan | $151,181,145 | $108,012,829 | $54,201,455 | |||||||
| 2023-24 plan | $74,043,627 | $68,409,104 | $48,948,263 | |||||||
| 2024-25 plan | $72,445,218 | $52,458,440 | $47,660,462 | |||||||
| 2025-26 plan | $54,879,733 | $53,107,345 | $43,588,541 | |||||||
| Actual | $51,630,185 | $68,566,332 | $63,260,409 | $67,937,429 | $81,039,024 | $92,955,556 | $69,107,286 |
Actual spending is from Departmental Results Reports and the Public Accounts, as published in GC InfoBase. FTEs are full-time equivalents.
